Akums Drugs & Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹1,050.26Cr
Net Profits
₹65.21Cr
Net Profit Margins
6.21%

Highlights

Revenue:

Akums Drugs & Pharmaceuticals Ltd’s revenue fell -11.6% since last year same period to ₹1,050.26Cr in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 2.4% jump in its revenue since last 3-months.

Net Profits:

Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 105% since last year same period to ₹65.21Cr in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 8.38% jump in its net profits since last 3-months.

Net Profit Margins:

Akums Drugs & Pharmaceuticals Ltd’s net profit margin jumped 131.89% since last year same period to 6.21% in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 5.84% jump in its net profit margins since last 3-months.

FAQs

The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹1,050.26Cr.

The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹65.21Cr.

The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was 6.21%.

The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2023 was ₹1,188.03Cr.

The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2023 was ₹31.81Cr.

The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q2 results 2023 was 2.68%.